2026 NPPES data Dermatology Physician NPI 1326034489 M.D.
Verify on CMS →

MARK KORY, M.D.

Dermatology Physician in CHESTERFIELD, Missouri. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
2K
Medicare Part D claims · 735 beneficiaries · Dermatology Physician avg: 729
Generic prescribing
95%
generic claims · 5% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
4.2246/100
▼ 79 pts below national avg 83.1 · [object Object]
Industry payments
$32.2K
305 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

MARK KORY, M.D. reported a CMS MIPS final score of 4.2246/100 — below the 83.1 national average — and filed 1,910 Medicare Part D claims in 2023.

4.2246/100
MIPS score · -79 vs avg
2K
Part D claims, 2023
95%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

MARK KORY, M.D.'s MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

4 1st percentile higher than 1% of 477,587 scored providers

0–10: 8,684 scored providers (2%). This entry sits in this band. 10–20: 3,008 scored providers (1%). Above this entry. 20–30: 3,069 scored providers (1%). Above this entry. 30–40: 2,746 scored providers (1%). Above this entry. 40–50: 2,928 scored providers (1%). Above this entry. 50–60: 5,882 scored providers (1%). Above this entry. 60–70: 13,906 scored providers (3%). Above this entry. 70–80: 118,074 scored providers (25%). Above this entry. 80–90: 129,887 scored providers (27%). Above this entry. 90–100: 189,403 scored providers (40%). Above this entry. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

MARK KORY, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about MARK KORY, M.D.?

Below national average

NPI registry status

Active

Issued 09/23/2005

NPI 1326034489

Primary specialty

Dermatology Physician

Mid-sized

14,610 US NPIs in this specialty

Medicare Part D claims

1,910 162% vs specialty avg

2023 prescription claims

Specialty avg: 729

MIPS final score

4.2246/100 78.8754% pts

Penalty band band

vs 83.1 national avg

Specialty distribution in Missouri

How Dermatology Physician compares to other specialties among Missouri providers

Missouri providers

Dermatology Physician share within Missouri

1. Dermatology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Dermatology Physician share within Missouri

Medicare quality performance — MIPS

MARK KORY, M.D.'s 2023 MIPS final score plotted against the Dermatology Physician national average

Below national average
MIPS Final Score
4.2246/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Dermatology Physician) — 4.2246/100 vs national avg 83.1

0%100%National avg83%4.2%
MIPS final score (Dermatology Physician) — 4.2246/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

MARK KORY, M.D. appears in the CMS NPPES registry as a Dermatology Physician provider holding M.D. credentials at 16216 BAXTER RD, CHESTERFIELD, MO, 63017, with a listed phone of (636) 532-1000. NPI 1326034489 was issued on 09/23/2005. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what KORY most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 1,910 prescription claims written by this provider, covering 735 Medicare beneficiaries and totaling roughly $403K in drug spend, split 5% brand-name and 95% generic by claim count, with an opioid prescribing rate of 2.7%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 4.2246/100 for the 2023 performance year (Quality 0, Cost 14.082), compared with the national average of 83.1.

Dermatology Physician is a mid-sized specialty nationwide, with 14,610 enrolled providers across 53 states and an average of 729 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

16216 BAXTER RD
CHESTERFIELD, MO 63017

Provider Details

NPI 1326034489
Specialty Dermatology Physician
Credentials M.D.
Gender Male
NPI Issued 09/23/2005

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

4.2246
Final Score
Avg: 83.1
0
Quality
14.082
Cost

Reporting: Individual

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for MARK KORY, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$32.2K

Largest payer

Arcutis Biotherapeutics, Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Brand vs generic prescribing mix · Generic-heavy

MARK KORY, M.D. — brand share 5.0%
Specialty average (est.)

5% brand-name claims vs 95% generic, on 1,910 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

1,910
Total Claims
$403K
Total Drug Cost
735
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
2,233
Total Day Supply
54,040
Brand vs Generic
5% brand / 95% generic
Brand Drug Cost
$344K
Generic Drug Cost
$58K
Opioid Claims
51 (2.7% rate)
Antibiotic Claims
251

Patient Demographics

Average Patient Age
74.4 years
Avg HCC Risk Score
0.97
Gender Split
56% female / 44% male
Age Distribution
<65: 18, 65-74: 363, 75-84: 276, 85+: 78

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What MARK KORY, M.D. prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Mupirocin
239
Triamcinolone Acetonide
209
Mometasone Furoate
164
Ketoconazole
159
Hydrocortisone
125
Metronidazole
108
Doxycycline Hyclate
103
Valacyclovir
Valacyclovir Hcl
76
Cefadroxil
71
Betamethasone Diprop Augmented
Betamethasone/Propylene Glyc
55

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Dermatology Physician Overview

How MARK KORY, M.D. fits within the Dermatology Physician landscape nationally.

14,610
Dermatology Physician Providers in US
53
States with Dermatology Physician
729
Avg Claims per Provider

MARK KORY, M.D.'s 1,910 claims are above the specialty average of 729.

Nearby Dermatology Physician Providers in Missouri

Other clinicians with the same primary specialty enrolled in Missouri, drawn from the same CMS NPPES roster as KORY.

Compare Dermatology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is MARK KORY, M.D.'s specialty?
MARK KORY, M.D. specializes in Dermatology Physician and practices in CHESTERFIELD, Missouri. Credentials: M.D..
How much does MARK KORY, M.D. prescribe under Medicare Part D?
In 2023, MARK KORY, M.D. wrote 1,910 Medicare Part D claims totaling $403K in drug costs for 735 beneficiaries.
What is MARK KORY, M.D.'s Medicare quality score?
MARK KORY, M.D. has a CMS MIPS Final Score of 4.2246/100 (Quality: 0, Cost: 14.082). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is MARK KORY, M.D. located?
MARK KORY, M.D. is located at 16216 BAXTER RD, CHESTERFIELD, MO, 63017. Phone: (636) 532-1000.
What is MARK KORY, M.D.'s NPI number?
MARK KORY, M.D.'s National Provider Identifier (NPI) is 1326034489, issued on 09/23/2005.
Does MARK KORY, M.D. prescribe more brand-name or generic drugs?
MARK KORY, M.D.'s prescribing is 5% brand-name and 95% generic drugs by claim count, with $344K in brand drug costs.
Does MARK KORY, M.D. prescribe opioids?
Yes, MARK KORY, M.D. had 51 opioid claims in 2023 with an opioid prescribing rate of 2.7%.
How many Dermatology Physician providers are there in the US?
There are 14,610 Dermatology Physician providers across 53 states in the US. The average Dermatology Physician provider writes 729 Medicare Part D claims per year.
What drugs does MARK KORY, M.D. prescribe most often?
Based on 2023 Medicare Part D data, MARK KORY, M.D.'s most frequently prescribed drugs include Mupirocin, Triamcinolone Acetonide, Mometasone Furoate. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does MARK KORY, M.D. accept Medicare?
MARK KORY, M.D. appears in CMS Medicare data with 1,910 Part D claims and 735 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify MARK KORY, M.D.'s credentials?
MARK KORY, M.D.'s NPI is 1326034489 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology